Navigation Links
Sosei in Medical News

Sosei Announces Start of AD 923 Phase III Studies in Europe

...OKYO, Japan, February 12 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...safety and tolerability of AD 923. In June 2006, sosei entered into an agreement with Mundipharma Interna...tional markets, excluding North America and Japan. sosei is currently evaluating its commercialisation opti...

Sosei Announces Approval to Start AD 923 Phase III Studies in Europe

... TOKYO, November 28 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...in the trial". Notes to Editors: About Sosei sosei Group Corporation is a leading international bioph...ckout system that prevents inadvertent overdosing. sosei has concluded a range of studies that confirm the ...

Sosei Announces Update on Phase I Trials for SD118

... TOKYO, November 27 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ction that lead to improved drugs. About Sosei sosei Group Corporation is a leading international bioph...s on its lead compound NSL-043 in partnership with sosei Group Corporation, a listed Japanese biopharmaceut...

Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD

...AM, England, November 15 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...o severe COPD. NVA237 was licensed to Novartis by sosei and Vectura in 2005 in a deal in which the two com... About the NVA237 licence agreement with Novartis sosei and its co-development partner Vectura Group plc c...
Sosei in Medical Technology

Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237

...riggers $7.5m Milestones for Both Companies sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...l trigger a $7.5 million milestone payment to both sosei and Vectura. The trial is a randomised, dou... NVA237 was licensed to Novartis in April 2005 by sosei and its co-development partner Vectura. Novartis i...

Sosei Confirms the Safety of SD118 in Two Phase I Trials

... TOKYO, December 8 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...esia A reduced sense of touch. About sosei sosei Group is a leading international biopharmaceutical...

Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting

...service provider and drug development Company, and sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...nflammatory pain." Mr Shinichi Tamura, CEO sosei Group added: "We are pleased to have collaborated ...opment compound NSL-043/SD118, in partnership with sosei Co. Ltd. Both of these trials reported a successfu...

NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

...lar findings. NVA237 was licensed to Novartis by sosei and Vectura in 2005 in a deal in which the two com...VA237 and QVA149 licence agreement with Novartis sosei and Vectura Group plc concluded a global developme...st, as QVA149. Under the terms of the agreement, sosei and Vectura to date have each received $15 million...

Sosei Announces Completion of Phase III Trial for NorLevo(R)

... TOKYO, July 10 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ncy contraceptive pill (ECP) SOH-075 (NorLevo(R)). sosei acquired the exclusive distribution rights to the ...d as an essential drug by the WHO. About Sosei sosei Group is a leading international biopharmaceutical...

Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA

... TOKYO, May 22, 2007 /PRNewswire-FirstCall/ -- sosei Group Corporation , a biopharmaceutical company, t...with no significant safety issues identified. sosei has reached agreement with EU regulatory authoriti...o Phase III studies." Notes for Editors: About sosei ...
Sosei in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...icenses Antibody-Drug Conjugates Development Rights to Genentech II-88 National Cancer Institute Enters into Agreement with Illumina II-89 sosei Seeks Marketing Rights for Prostate Cancer Drug in Japan II-89 8. Focus on Select Global Players II-90 Abbott Laboratories (USA) II-90 Ae...

Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria

... Based on its cytokine modulatory activity, sosei were developing RS(+) mefloquine as AD 452 for the...es over existing treatment options." About sosei sosei Group is a leading international biopharmaceutical...

Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))

... TOKYO, October 22 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...he biopharmaceutical company, today announced that sosei Co., Ltd., its wholly owned Japanese subsidiary, h... oral emergency contraceptive for post-coital use. sosei acquired the exclusive distribution rights to the ...

WWMR, Inc. Announces Launch of New Pain Clinic Monitor

...Reckitt Benckiser/Vernalis, Durect, Rinat Neuroscience/Pfizer, Elan Pharm, Roche, Eli Lilly, Sanofi-Aventis, Endo Pharm, Schwarz, Forest Laboratories, sosei R&D, Gedeon Richter, Teikoku Seiyaku, GlaxoSmithKline, TheraQuest, Grunenthal, Vernalis, GW Pharmaceuticals, Watson Pharm, Janssen-Cilag, Wyeth Pharma...

Sosei Announces Outcome of Strategy Review

... TOKYO, May 14 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ness from NVA237/QVA149 in a few years time. - sosei is closing its Chesterford operation and sosei R&D's continuing business will relocate to London...

Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities

... Prior to Marquant, Joy's positions included: Vice President, Business Development at Nabi Biopharmaceuticals; Vice President, Business Development at sosei Co. Ltd; Commercial Director at Xenova Group Limited; member of the Pharmaceuticals and Medical Products practice at Accenture; and various roles in t...

Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome

... TOKYO, September 18 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456... potential indications." Notes to Editors: About sosei sosei Group Corporation is a leading international bioph...
Other Tags
(Date:8/1/2014)... 2014 Surftech athletes Jack Bark and ... World Championships this past weekend in Hawaii in commanding ... finisher Zeb Walsh were all on stock Surftech Bark ... race and athletes this year were treated to 6-10 ... course extremely challenging as well as very fast. ...
(Date:8/1/2014)... 01, 2014 iFitDress.com, a professional company ... new collection of 2014 silver bridesmaid dresses ... according to the latest fashion trends. What’s more, they ... 55 percent off. , iFitDress.com is one of ... in not only silver bridesmaid gowns, but also many ...
(Date:7/31/2014)... 2014) Women over the age of 65 face ... obesity, greater struggles against poverty and higher rates of ... the August issue of Annals of Allergy, Asthma ... College of Allergy, Asthma and Immunology (ACAAI), outlines the ... offers practical solutions to improve their care. ...
(Date:7/31/2014)... Developer Jamestown, L.P., has been using ... City Market project in Atlanta’s Old Fourth Ward, which ... building into best-in-class office, housing, and retail spaces. As ... with their construction webcam service to assess how it ... construction camera for monitoring and documentation purposes, ...
(Date:7/31/2014)... 31, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
Breaking Medicine News(10 mins):Health News:Surftech Bark Commander Sweeps Molokai2Oahu Stock Paddleboard Division 2Health News:iFitDress.com: Beautiful Silver Bridesmaid Dresses at Promotional Prices 2Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
(Date:7/31/2014)... A first-of-its-kind study of bigeye tuna movements in the ... the Large Pelagics Research Center at the University of ... cover a wide geographical range with pronounced north-south movements ... favor a high-use area off Cape Hatteras southwest of ... a new approach to study one of the most ...
(Date:7/31/2014)... GAINESVILLE, Fla. --- By tracing nearly 3,000 genes ... moths, University of Florida scientists have created an ... to use large-scale, next-generation DNA sequencing. , ... more closely related to small moths than to ... how butterflies evolved. The study also found that ...
(Date:7/31/2014)... has long been known that biomass burning ... as a ritual , slash-and-burn agriculture and wildfires ... health. , But until the release of a ... Engineering Professor Mark Z. Jacobson, the degree of ... Jacobson,s research, detailed in a paper published July ...
Breaking Biology News(10 mins):Study of bigeye tuna in Northwest Atlantic uses new tracking methods 2Study of bigeye tuna in Northwest Atlantic uses new tracking methods 3UF study advances 'DNA revolution,' tells butterflies' evolutionary history 2UF study advances 'DNA revolution,' tells butterflies' evolutionary history 3Stanford professor finds that wildfires and other burns play bigger role in climate change 2Stanford professor finds that wildfires and other burns play bigger role in climate change 3Stanford professor finds that wildfires and other burns play bigger role in climate change 4
Other Contents